EADV Symposium 2026: 07-09 May 2026

The annual EADV Symposium stands as a premier international gathering devoted to dermatology and venereology, offering a dynamic platform for exchanging knowledge, collaboration, and presenting cutting-edge research findings.

EADV Symposium 2026
07-09 May 2026
Athens, Greece

https://eadv.org/symposium/


Xinnate granted patent in Japan for TCP-25 formulation. The patent further strengthens the global intellectual property protection of the TCP-25 gel.

The granted patent is broad in scope and covers both the formulation currently being used in the international clinical study STEP as well as future generations of products containing TCP-25.

TCP-25 is already protected by patents in Europe and the United States and has also been granted Orphan Drug Designation in the United States.

“A strong intellectual property position is essential for us, and this new patent provides broad protection in a strategically important market,” says Helene Hartman, CEO of Xinnate AB.


EB 2026: 20-22 Jan 2026

Xinnate’s CMO Professor Artur Schmidtchen, MD, will be speaking at the EB 2026 International Congress.

EB 2026 International Congress
20-22 Jan 2026
São Paulo, Brazil

https://www.eb2026.com.br/palestrantes-e-convidados/artur-schmidtchen


EB Awareness week: 25-31 Oct 2025

Spread awareness of Epidermolysis Bullosa. A group of rare genetic conditions that cause extremely fragile skin.

EB Awareness week: 25-31 October 2025


This EB Awareness Week, Xinnate stands with the EB community to spread knowledge and hope. To support and raise awareness, visit patient organisation debra.org


NLS Days: 13-14 Oct 2025

Meet our CEO Helene Hartman at the NLS days.

Nordic Life Science (NLS) Days
13-14 October 2025
Gothenburg, Sweden

 


ESDR MEETING: 10-13 Sep 2025

Xinnate’s CMO Professor Artur Schmidtchen, MD, will speak at the ESDR 2025

54th ANNUAL ESDR MEETING
10-13 Sep 2025
Antwerp, Belgium

https://esdrmeeting.org/program/speakers/artur-schmidtchen/